Biological Synthesis of Silver Nanoparticles with Aqueous Extract of Azadirachta indica Leaf and Its Antimicrobial Activity on Uropathogenic MDR and ESBL Producing Escherichia coli.

This study demonstrates that silver nanoparticles biosynthesized using *Azadirachta indica* leaf extract effectively inhibit multidrug-resistant and ESBL-producing *E. coli* strains while exhibiting low cytotoxicity to human kidney cells, suggesting their potential as a therapeutic agent for drug-resistant infections.

The Gist

Imagine you are fighting a war against a super-villain army. These villains are bacteria (specifically E. coli) that live in our urinary tracts. But these aren't ordinary villains; they are "super-bugs." They have built impenetrable shields (called MDR and ESBL) that make standard antibiotics useless. Doctors are running out of weapons to stop them.

Enter our hero: Silver Nanoparticles. Think of these as microscopic, silver bullets. For thousands of years, people knew silver could stop germs (like how Romans used silver coins in water jars), but making them tiny enough to work inside the body without being toxic is tricky. Usually, scientists make these bullets using harsh, toxic chemicals—like using a sledgehammer to crack a nut.

This paper introduces a smarter, greener way to make these silver bullets using Neem leaves (Azadirachta indica).

Here is the story of how the author, Payel Das, did it, explained simply:

1. The Recipe: Cooking with Nature

Instead of using dangerous chemicals, the researcher took fresh Neem leaves (a plant famous in India for its healing powers) and boiled them in water. This created a "tea" full of natural chemicals.

Then, she mixed this "Neem tea" with a silver solution (Silver Nitrate).

• The Magic Moment: When mixed, the liquid changed color from clear to a deep brown.
• The Analogy: Imagine the Neem tea as a team of tiny, invisible chefs. They grabbed the silver atoms and shrunk them down into tiny, perfect spheres. The color change was the "ding!" of the oven, telling us the silver bullets were ready.

2. The Inspection: Are the Bullets Good?

Before sending these bullets into battle, the scientist had to check their quality using high-tech microscopes and scanners.

• Shape & Size: The bullets were perfectly round and smooth, about 74 nanometers wide. To put that in perspective, if a silver bullet were the size of a marble, a human hair would be as wide as a football stadium.
• Stability: They were coated in a "protective suit" made of the Neem plant's own chemicals. This suit keeps the bullets from clumping together and ensures they stay stable.
• The Result: The inspection confirmed they were high-quality, face-centered cubic crystals (a fancy way of saying they are perfectly structured).

3. The Battle: Fighting the Super-Bugs

The researcher tested these Neem-made silver bullets against the "super-bug" E. coli strains that resist normal medicine.

• The Result: The silver bullets worked incredibly well!
  • Stopping the enemy (MIC): It took a very tiny amount (about 9.5 micrograms) to stop the bacteria from growing.
  • Killing the enemy (MBC): It took a slightly higher dose (about 121 micrograms) to actually kill them off.
• The Comparison: The Neem leaf tea alone couldn't stop the super-bugs. It needed the silver bullets to do the heavy lifting. The Neem was just the factory; the silver was the weapon.

4. The Safety Check: Will it hurt us?

The biggest worry with silver bullets is: "Will they hurt the good guys (our human cells)?"

• The researcher tested the bullets on human kidney cells (the kind of cells found in the urinary tract).
• The Result: The bullets were very safe for human cells. It took a dose 369 micrograms to start hurting the human cells.
• The Analogy: Think of it like a sniper. The silver bullets can hit the enemy (bacteria) from a mile away with a tiny shot, but they need a massive, direct hit to hurt a human. This means there is a huge "safety margin." We can use enough to kill the bacteria without hurting the patient.

The Big Picture

This study is like finding a green, eco-friendly factory that can mass-produce super-weapons against drug-resistant bacteria.

• Old Way: Use toxic chemicals to make silver bullets (bad for the environment, expensive).
• New Way: Boil Neem leaves, mix with silver, and get a powerful, safe, and cheap weapon.

Conclusion:
The paper concludes that we can use this "Neem-Silver" combo to fight the super-bugs that are currently winning the war against antibiotics. It's a promising, nature-based solution that could help doctors treat difficult infections in the future, provided we test it further in living animals and humans.

In short: Nature (Neem) + Science (Silver) = A powerful new shield against super-bacteria, made safely and cheaply.

Technical Summary

1. Problem Statement

The global rise of multidrug-resistant (MDR) and extended-spectrum beta-lactamase (ESBL) producing Escherichia coli strains poses a critical threat to public health, particularly in low- and middle-income countries where urinary tract infections (UTIs) are prevalent. Conventional antibiotics are increasingly ineffective against these clinical isolates. While silver nanoparticles (AgNPs) show promise as antimicrobial agents, traditional chemical synthesis methods involve toxic reagents and high energy consumption. Furthermore, there is a need to develop AgNPs that are not only potent against resistant bacteria but also exhibit low cytotoxicity to human cells. This study addresses the need for an eco-friendly, cost-effective "green synthesis" method using Azadirachta indica (Neem) to produce stable AgNPs capable of targeting resistant uropathogenic E. coli.

2. Methodology

The research followed a structured workflow involving plant identification, nanoparticle synthesis, comprehensive characterization, and biological evaluation.

• Plant Material & Identification: Fresh Azadirachta indica leaves were collected from Kolkata, India. Species identity was confirmed via genomic DNA isolation and PCR amplification of the 18S rRNA gene, yielding a specific 230 bp band.
• Green Synthesis (AI-AgNPs):
  • An aqueous extract was prepared by boiling 20g of chopped leaves in 100ml Milli-Q water.
  • Silver nitrate (AgNO₃) solution (10⁻² M) was mixed with varying concentrations (2%–10%) of the neem extract.
  • The reaction was monitored at room temperature. The optimal concentration was determined based on the intensity of the Surface Plasmon Resonance (SPR) peak.
  • Nanoparticles were harvested via centrifugation (up to 15,000 rpm) and washed.
• Characterization:
  • UV-Vis Spectroscopy: Monitored for SPR peaks (300–600 nm) over 96 hours.
  • FTIR: Analyzed functional groups responsible for capping and stabilization (4000–400 cm⁻¹).
  • XRD: Determined crystalline structure, phase composition, and crystallite size using the Debye-Scherrer equation.
  • DLS & Zeta Potential: Measured hydrodynamic size, polydispersity index (PDI), and surface charge for stability assessment.
  • SEM & TEM: Visualized morphology, surface texture, and precise particle size.
  • EDAX: Confirmed elemental composition.
• Biological Assays:
  • Antimicrobial Activity: Tested against 88 clinical MDR/ESBL E. coli isolates. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) were determined using a microdilution method with INT (Iodonitrotetrazolium) colorimetric assay.
  • Cytotoxicity: Evaluated on the Human Embryonic Kidney (HEK-293) cell line using the MTT assay to determine the IC₅₀ value.

3. Key Contributions

• Optimization of Green Synthesis: The study identified 4% neem leaf extract as the optimal concentration for synthesizing AgNPs, yielding a strong SPR peak at 440 nm without secondary peaks associated with larger, less stable particles.
• Mechanistic Insight: The research elucidates the dual role of neem phytochemicals (terpenoids and flavanones) as both reducing agents (converting Ag⁺ to Ag⁰) and capping agents (stabilizing the nanoparticles).
• Targeted Clinical Application: Unlike many studies using standard lab strains, this work specifically targets clinical isolates of MDR and ESBL-producing E. coli, which are highly relevant to current antibiotic resistance crises.
• Safety Profile: The study provides a comparative analysis demonstrating a wide therapeutic window between the bactericidal concentration and the cytotoxic concentration on normal human cells.

4. Key Results

• Synthesis & Stability:

  • Successful synthesis was confirmed by a color change from pale yellow to brown.
  • UV-Vis: A strong SPR peak was observed at 440 nm (indicating spherical AgNPs) with 4% extract. Stability plateaued after 72 hours.
  • FTIR: Peaks at 3429 cm⁻¹ (O-H/N-H), 1653 cm⁻¹ (C=C), and 1097 cm⁻¹ (Ether linkage) confirmed that biomolecules from the leaf extract capped the nanoparticles.
  • XRD: Confirmed a Face-Centered Cubic (FCC) crystalline structure. The average crystallite size was 73.67 nm. Minor peaks indicated the presence of chlorargyrite (AgCl), suggesting a reaction between Ag⁺ and chloride ions in the extract.
  • DLS/Zeta: Average hydrodynamic size was 73.74 nm with a PDI of 0.368 (slightly polydisperse). The Zeta potential was -28.04 mV, indicating moderate electrostatic stability.
  • SEM/TEM: Confirmed smooth, spherical morphology. TEM measured an average size of 73.51 ± 13.11 nm (range 57–98 nm).
  • EDAX: Confirmed the presence of Silver (61.3%) and Chlorine (15.9%), along with Carbon and Oxygen from the capping agents.

• Antimicrobial Efficacy:

  • MIC: The average MIC against MDR/ESBL E. coli was 9.5 µg/mL.
  • MBC: The average MBC was 121 µg/mL.
  • The neem extract alone showed no significant inhibitory effect at the tested concentrations, confirming that the antimicrobial activity is due to the synthesized nanoparticles.

• Cytotoxicity:

  • The IC₅₀ value for HEK-293 cells was 369 µg/mL.
  • Therapeutic Index: The IC₅₀ (369 µg/mL) is significantly higher than the MBC (121 µg/mL), suggesting that the nanoparticles are effective against bacteria at concentrations that are relatively safe for normal human kidney cells.

5. Significance and Conclusion

This study demonstrates that Azadirachta indica leaf extract is a highly effective, eco-friendly medium for the biosynthesis of stable silver nanoparticles. The resulting AI-AgNPs exhibit potent antibacterial activity against clinically relevant, drug-resistant E. coli strains (MDR and ESBL producers) while maintaining a favorable safety profile for normal human cells.

The research highlights a potential solution for the growing crisis of antimicrobial resistance, particularly for urinary tract infections. The nanoparticles offer a biocompatible alternative to chemical synthesis, with potential applications in antimicrobial coatings for medical devices (e.g., catheters), wound dressings, and therapeutic interventions. The authors conclude that while the in vitro results are promising, future in vivo studies are necessary to validate pharmacokinetics and therapeutic efficacy before clinical translation.